Search
for
Sort by
Research 151–180 of 168
- Introduction to Toxins Special Issue on Botulinum Toxins: New Uses in the Treatment of Diseases (2nd Edition)
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Resolution of experimental malaria-associated acute respiratory distress syndrome is Alox12 independent and shows residual inflammation
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- Effect of platelet-rich plasma in treating musculoskeletal disorders in athletes
- Strategies for Optimizing Acute Burn Wound Therapy: A Comprehensive Review
- Exploring links between acne and metabolic syndrome: a narrative review
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Thallium - poisoner’s poison: An overview and review of current knowledge on the toxicological effects and mechanisms
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Platelet-rich Plasma and Its Application in Clinical Trial
- Painful, Unexplained Peripheral Neuropathy? Think Thallium Toxicity
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Serum Levels of VWF, t-PA, TNF-α, and ICAM-1 in Patients Receiving Hemocoagulase Combined with Platelet-Rich Plasma during Total Hip Replacement
- Role of Growth Factors-Rich Plasma, Gel and Membrane in Dermal Wound Healing and Injured Tissue Restoration and Regeneration
- The Wonder Tool Platelet Rich Plasma in Cosmetic Dermatology, Trichology and Hair Transplant
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Immunomodulators in the treatment of cutaneous lymphoma
- Connubial Androgenetic Alopecia
- Skin manifestations of chronic kidney disease
- Current management strategies for cutaneous T-cell lymphoma
- Alopecia Universalis Associated with Cutaneous T Cell Lymphoma
- Chronic graft-versus-host disease – the role of dermatological treatment
- Interferon in the treatment of cutaneous T-cell lymphoma
- INTERFERONS IN DERMATOLOGY
- Secondary cicatricial and other permanent alopecias
- Skin manifestations of chronic kidney disease
- The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument
- Principles of Therapy of Skin Diseases